Upload Image (Max 20MB per Image)
Teijin Pharma will launch Ipsen's Somatuline subcutaneous injection in 60mg, 90mg and 120mg doses, indicated to treat acromegaly and pituitary gigantism, in Japan. The medication is indicated for acromegaly and pituitary gigantism ...
Tags: Teijin Pharma, Ipsen Somatuline, surgical therapies